94 related articles for article (PubMed ID: 17433967)
1. Three-year single institution audit on transfusion requirements in oncology patients.
Dernedde U; Dernedde R; Shepstone L; Barrett A
Clin Oncol (R Coll Radiol); 2007 May; 19(4):223-7. PubMed ID: 17433967
[TBL] [Abstract][Full Text] [Related]
2. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
Biesma B; van de Werf PR; Melissant CF; Brok RG
Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy.
Kader AS; Lim JT; Berthelet E; Petersen R; Ludgate D; Truong PT
Am J Clin Oncol; 2007 Oct; 30(5):492-7. PubMed ID: 17921709
[TBL] [Abstract][Full Text] [Related]
4. Risks, benefits, alternatives and indications of allogenic blood transfusions.
Madjdpour C; Heindl V; Spahn DR
Minerva Anestesiol; 2006 May; 72(5):283-98. PubMed ID: 16675937
[TBL] [Abstract][Full Text] [Related]
5. [Erythropoietic protein supportive treatment in small cell lung cancer].
Tamási L; Müller V; Magyar P; Losonczy G
Magy Onkol; 2008 Mar; 52(1):43-6. PubMed ID: 18403296
[TBL] [Abstract][Full Text] [Related]
6. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy.
Barrett-Lee PJ; Bailey NP; O'Brien ME; Wager E
Br J Cancer; 2000 Jan; 82(1):93-7. PubMed ID: 10638973
[TBL] [Abstract][Full Text] [Related]
7. Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy.
Suzuki Y; Tokuda Y; Fujiwara Y; Minami H; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2008 Mar; 38(3):214-21. PubMed ID: 18296425
[TBL] [Abstract][Full Text] [Related]
8. Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer.
Melis M; McLoughlin JM; Dean EM; Siegel EM; Weber JM; Shah N; Kelley ST; Karl RC
J Surg Res; 2009 May; 153(1):114-20. PubMed ID: 19201421
[TBL] [Abstract][Full Text] [Related]
9. Cancer anemia survey in Division of Medical Oncology at Siriraj Hospital (CAS).
Ithimakin S; Srimuninnimit V
J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S110-8. PubMed ID: 19562994
[TBL] [Abstract][Full Text] [Related]
10. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
Aapro M; Leonard RC; Barnadas A; Marangolo M; Untch M; Malamos N; Mayordomo J; Reichert D; Pedrini JL; Ukarma L; Scherhag A; Burger HU
J Clin Oncol; 2008 Feb; 26(4):592-8. PubMed ID: 18235117
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
[TBL] [Abstract][Full Text] [Related]
12. Practice and costs of red blood cell (RBC) transfusion in an oncological unit.
Norum J; Moen MA
Anticancer Res; 2008; 28(1B):459-64. PubMed ID: 18383885
[TBL] [Abstract][Full Text] [Related]
13. Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer.
Panagopoulos ND; Karakantza M; Koletsis E; Apostolakis E; Sakellaropoulos GC; Filos KS; Eleni T; Dougenis D
Lung Cancer; 2008 Nov; 62(2):273-80. PubMed ID: 18430486
[TBL] [Abstract][Full Text] [Related]
14. Is it necessary to check outcomes to improve quality of care? The example of anemia management.
Di Benedetto A; Richards N; Marcelli D; Basci A; Cesare S; Ponce P; Scatizzi L; Marotta P
J Nephrol; 2008; 21 Suppl 13():S146-52. PubMed ID: 18446749
[TBL] [Abstract][Full Text] [Related]
15. [The occurrence of anemia in small cell lung cancer patients during first-line chemotherapy].
Swiatoniowski G; Bruzewicz S; Bronowicz Z; Kłaniewski T
Pol Merkur Lekarski; 2009 Feb; 26(152):98-100. PubMed ID: 19388511
[TBL] [Abstract][Full Text] [Related]
16. Improvement in fresh frozen plasma transfusion practice: results of an outcome audit.
Kakkar N; Kaur R; Dhanoa J
Transfus Med; 2004 Jun; 14(3):231-5. PubMed ID: 15180815
[TBL] [Abstract][Full Text] [Related]
17. Transfusion requirements in patients with malignancy.
Aledort LM; Mohandas K
Semin Hematol; 1996 Jan; 33(1 Suppl 1):6-9. PubMed ID: 8714609
[No Abstract] [Full Text] [Related]
18. The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model.
Borg S; Glenngård AH; Osterborg A; Persson U
Acta Oncol; 2008; 47(6):1009-17. PubMed ID: 18770060
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
Dietl B; Marienhagen J; Schäfer C; Kölbl O
Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
[TBL] [Abstract][Full Text] [Related]
20. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
